Clinical trial
Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
NCT00005002 · Agouron Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00005002 |
|---|---|
| Title | Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune) |
| Official title | A Randomized, Double-Blind, Adjuvant-Controlled, Multicenter Study to Compare the Virologic and Immunologic Effect of Highly Active Antiretroviral Therapy (HAART) Plus Remune Versus HAART Plus Incomplete Freund's Adjuvant (IFA) in Antiretroviral-Naive Patients Infected With Human Immunodeficiency… |
| Lead sponsor | Agouron Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological, Drug |
| Interventions | Lamivudine/Zidovudine, HIV-1 Immunogen, Nelfinavir mesylate |
| Enrollment | 688 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: